Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients

NCT05838716 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT05838716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05838716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients
Lead sponsor
University of Rochester
Phase
Phase 3
Overall status
Recruiting
Start date
December 14, 2023
Completion date
April 29, 2029
Enrollment
240 (estimated)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

stage i prostate cancer ajcc v8, stage ii prostate cancer ajcc v8, stage iii prostate cancer ajcc v8, stage iva prostate cancer ajcc v8